Optical Control of Mononegavirus Gene Expression and Replication

Area of Science:

• Virology
• Gene Therapy
• Biotechnology

Background:

• Mononegaviruses show promise as oncolytic and transgene vectors for gene therapy and regenerative medicine.
• Strict control of viral activity is crucial for therapeutic applications to mitigate toxicity and side effects.

Purpose of the Study:

• To develop a method for controlling mononegavirus vector activity using external stimuli.
• To enhance the safety and controllability of mononegavirus-based gene therapy vectors.

Main Methods:

• Incorporation of a photoswitch protein (Magnet) into the mononegavirus L protein to disrupt its function.
• Utilizing blue light (470 nm) irradiation to induce dimerization of Magnet domains, thereby restoring L protein activity and enabling viral replication.
• Demonstrating the reversibility of Magnet dimerization to cease viral gene expression and replication upon removal of blue light.

Main Results:

• The Magnet protein effectively disrupts mononegavirus L protein function in the absence of blue light.
• Blue light irradiation reversibly restores L protein activity, leading to controlled viral gene expression and replication.
• This photoswitchable system allows for precise temporal and spatial control over mononegavirus vector activity.

Conclusions:

• The developed photoswitchable mononegavirus vector system provides a novel strategy for tightly regulating viral activity.
• This technology enhances the safety profile of mononegavirus vectors, making them more suitable for therapeutic applications in gene therapy and regenerative medicine.
• The ability to switch viral replication on and off with light offers unprecedented control for future biomedical applications.